Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)
Status: Enrolling
Updated:  1/31/2013
Urology San Antonio Research
mi
from
San Antonio, TX
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)
Status: Enrolling
Updated: 1/31/2013
Urology San Antonio Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)
Status: Enrolling
Updated:  1/31/2013
Southern Interior Medical Research Inc.
mi
from
Kelowna,
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)
Status: Enrolling
Updated: 1/31/2013
Southern Interior Medical Research Inc.
mi
from
Kelowna,
Click here to add this to my saved trials
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated:  2/5/2013
Johns Hopkins University
mi
from
Baltimore, MD
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated: 2/5/2013
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated:  2/5/2013
Dana-Farber Cancer Institute
mi
from
Boston, MA
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated: 2/5/2013
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated:  2/5/2013
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated: 2/5/2013
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated:  2/5/2013
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated: 2/5/2013
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated:  2/5/2013
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated: 2/5/2013
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated:  2/5/2013
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated: 2/5/2013
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated:  2/5/2013
The University of Texas M. D. Anderson Cancer Center
mi
from
Houston, TX
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated: 2/5/2013
The University of Texas M. D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated:  2/5/2013
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
Status: Enrolling
Updated: 2/5/2013
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
An Open-Label, Single-Arm, Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  2/5/2013
University of Texas Health Science Center
mi
from
San Antonio, TX
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
An Open-Label, Single-Arm, Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 2/5/2013
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Foundation for Cancer Research and Education
mi
from
Phoenix, AZ
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Foundation for Cancer Research and Education
mi
from
Phoenix, AZ
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Urological Surgeons of Northern California
mi
from
Campbell, CA
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Urological Surgeons of Northern California
mi
from
Campbell, CA
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Radiological Associates of Sacramento
mi
from
Sacramento, CA
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Radiological Associates of Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
The Urology Center of Colorado
mi
from
Denver, CO
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
The Urology Center of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Lakewood Ranch Oncology Center/21st Century Oncology
mi
from
Bradenton, FL
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Lakewood Ranch Oncology Center/21st Century Oncology
mi
from
Bradenton, FL
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
21st Century Oncology
mi
from
Plantation, FL
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
21st Century Oncology
mi
from
Plantation, FL
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Emory University
mi
from
Atlanta, GA
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Johns Hopkins University Department of Radiation Oncology and Molecular Radiation Sciences
mi
from
Baltimore, MD
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Johns Hopkins University Department of Radiation Oncology and Molecular Radiation Sciences
mi
from
Baltimore, MD
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Chesapeake Urology Associates, Chesapeake Urology Research Associates (The Prostate Center)
mi
from
Owings Mills, MD
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Chesapeake Urology Associates, Chesapeake Urology Research Associates (The Prostate Center)
mi
from
Owings Mills, MD
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Northern Nevada Radiation Oncology
mi
from
Reno, NV
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Northern Nevada Radiation Oncology
mi
from
Reno, NV
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
CentraState Medical Center
mi
from
Freehold, NJ
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
CentraState Medical Center
mi
from
Freehold, NJ
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Western New York Urology Associates, LLC and D/B/A Cancer Care of WNY
mi
from
Erie, Niagara, and Chautauqua County, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Western New York Urology Associates, LLC and D/B/A Cancer Care of WNY
mi
from
Erie, Niagara, and Chautauqua County, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Advanced Radiation Centers of New York
mi
from
Lake Success, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Advanced Radiation Centers of New York
mi
from
Lake Success, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
University of Rochester
mi
from
Rochester, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Upstate Medical University
mi
from
Syracuse, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Associated Medical Professionals of NY
mi
from
Syracuse, NY
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Associated Medical Professionals of NY
mi
from
Syracuse, NY
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Oregon Urology Institute
mi
from
Springfield, OR
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Oregon Urology Institute
mi
from
Springfield, OR
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
21st Century Oncology
mi
from
Myrtle Beach, SC
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
21st Century Oncology
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated:  2/13/2013
Peninsula Cancer Center
mi
from
Poulsbo, WA
SpaceOAR System Pivotal Study
Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study
Status: Enrolling
Updated: 2/13/2013
Peninsula Cancer Center
mi
from
Poulsbo, WA
Click here to add this to my saved trials
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
A Randomized, Open-Label, Neoadjuvant Prostate Cancer Trial of Abiraterone Acetate Plus LHRHa Versus LHRHa Alone
Status: Enrolling
Updated:  3/7/2013
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
A Randomized, Open-Label, Neoadjuvant Prostate Cancer Trial of Abiraterone Acetate Plus LHRHa Versus LHRHa Alone
Status: Enrolling
Updated: 3/7/2013
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
A Randomized, Open-Label, Neoadjuvant Prostate Cancer Trial of Abiraterone Acetate Plus LHRHa Versus LHRHa Alone
Status: Enrolling
Updated:  3/7/2013
Clinical Research Facility
mi
from
Dallas, TX
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
A Randomized, Open-Label, Neoadjuvant Prostate Cancer Trial of Abiraterone Acetate Plus LHRHa Versus LHRHa Alone
Status: Enrolling
Updated: 3/7/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
Status: Enrolling
Updated:  3/8/2013
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
Status: Enrolling
Updated: 3/8/2013
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
Status: Enrolling
Updated:  3/8/2013
James A. Haley VA Hospital
mi
from
Tampa, FL
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
Status: Enrolling
Updated: 3/8/2013
James A. Haley VA Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy
Assessing PSA Response in Low Dose Ketoconazole in Hormone Refractory Prostate Cancer Patients Who Have Failed at Least One Prior Systemic Chemotherapy Regimen
Status: Enrolling
Updated:  3/11/2013
University of California Davis Cancer Center
mi
from
Sacramento, CA
Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy
Assessing PSA Response in Low Dose Ketoconazole in Hormone Refractory Prostate Cancer Patients Who Have Failed at Least One Prior Systemic Chemotherapy Regimen
Status: Enrolling
Updated: 3/11/2013
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study of Dasatinib, Androgen Deprivation Therapy and Radiation
A Phase I Study of Dasatinib, Androgen Deprivation Therapy and Radiation For Intermediate and High Risk Prostate Cancer
Status: Enrolling
Updated:  4/4/2013
Rhode Island Hospital
mi
from
Providence, RI
Study of Dasatinib, Androgen Deprivation Therapy and Radiation
A Phase I Study of Dasatinib, Androgen Deprivation Therapy and Radiation For Intermediate and High Risk Prostate Cancer
Status: Enrolling
Updated: 4/4/2013
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Study of Dasatinib, Androgen Deprivation Therapy and Radiation
A Phase I Study of Dasatinib, Androgen Deprivation Therapy and Radiation For Intermediate and High Risk Prostate Cancer
Status: Enrolling
Updated:  4/4/2013
Miriam Hospital
mi
from
Providence, RI
Study of Dasatinib, Androgen Deprivation Therapy and Radiation
A Phase I Study of Dasatinib, Androgen Deprivation Therapy and Radiation For Intermediate and High Risk Prostate Cancer
Status: Enrolling
Updated: 4/4/2013
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Phase 2 Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot (Zoladex®) in Men With Prostate Cancer
Status: Enrolling
Updated:  5/8/2013
The Urology Center of Colorado
mi
from
Denver, CO
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Phase 2 Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot (Zoladex®) in Men With Prostate Cancer
Status: Enrolling
Updated: 5/8/2013
The Urology Center of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Phase 2 Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot (Zoladex®) in Men With Prostate Cancer
Status: Enrolling
Updated:  5/8/2013
Urology Clinics of North Texas
mi
from
Dallas, TX
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Phase 2 Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot (Zoladex®) in Men With Prostate Cancer
Status: Enrolling
Updated: 5/8/2013
Urology Clinics of North Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Phase 2 Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot (Zoladex®) in Men With Prostate Cancer
Status: Enrolling
Updated:  5/8/2013
Urology San Antonio Research
mi
from
San Antonio, TX
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Phase 2 Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot (Zoladex®) in Men With Prostate Cancer
Status: Enrolling
Updated: 5/8/2013
Urology San Antonio Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Statin Therapy Versus Placebo Prior to Prostatectomy
Pre-Operative Statin Therapy Versus Placebo in Human Prostate Cancer
Status: Enrolling
Updated:  5/20/2013
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Statin Therapy Versus Placebo Prior to Prostatectomy
Pre-Operative Statin Therapy Versus Placebo in Human Prostate Cancer
Status: Enrolling
Updated: 5/20/2013
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
Statin Therapy Versus Placebo Prior to Prostatectomy
Pre-Operative Statin Therapy Versus Placebo in Human Prostate Cancer
Status: Enrolling
Updated:  5/20/2013
VA Medical Center, Portland
mi
from
Portland, OR
Statin Therapy Versus Placebo Prior to Prostatectomy
Pre-Operative Statin Therapy Versus Placebo in Human Prostate Cancer
Status: Enrolling
Updated: 5/20/2013
VA Medical Center, Portland
mi
from
Portland, OR
Click here to add this to my saved trials
Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
Randomized, Open-Label Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
Status: Enrolling
Updated:  5/20/2013
University of Wisconsin Hospital and Clinics (Carbone Cancer Center)
mi
from
Madison, WI
Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
Randomized, Open-Label Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
Status: Enrolling
Updated: 5/20/2013
University of Wisconsin Hospital and Clinics (Carbone Cancer Center)
mi
from
Madison, WI
Click here to add this to my saved trials
MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer
MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer. A Phase III Study
Status: Enrolling
Updated:  5/28/2013
Arthur Smith Institute for Urology
mi
from
New Hyde Park, NY
MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer
MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer. A Phase III Study
Status: Enrolling
Updated: 5/28/2013
Arthur Smith Institute for Urology
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)
H-25362: Effect of Botulinum Neurotoxin Type A Prostate Injections on Neurogenesis and Gene Profile Expression in Men With Localized Prostate Cancer and Lower Urinary Tract Symptoms/BPH (Protocol # 05-09-30-03)
Status: Enrolling
Updated:  6/17/2013
University of Texas- Houston Medical School
mi
from
Houston, TX
BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)
H-25362: Effect of Botulinum Neurotoxin Type A Prostate Injections on Neurogenesis and Gene Profile Expression in Men With Localized Prostate Cancer and Lower Urinary Tract Symptoms/BPH (Protocol # 05-09-30-03)
Status: Enrolling
Updated: 6/17/2013
University of Texas- Houston Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Status: Enrolling
Updated:  6/25/2013
Clarian North Medical Center
mi
from
Carmel, IN
Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Status: Enrolling
Updated: 6/25/2013
Clarian North Medical Center
mi
from
Carmel, IN
Click here to add this to my saved trials
Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Status: Enrolling
Updated:  6/25/2013
Indiana University School of Medicine
mi
from
Indianapolis, IN
Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Status: Enrolling
Updated: 6/25/2013
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Status: Enrolling
Updated:  6/25/2013
Urology San Antonio Research
mi
from
San Antonio, TX
Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
Status: Enrolling
Updated: 6/25/2013
Urology San Antonio Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects With Prostate Cancer
Status: Enrolling
Updated:  7/15/2013
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects With Prostate Cancer
Status: Enrolling
Updated: 7/15/2013
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials